We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+13.12%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$22.4B
AUM Growth
+$2.53B
Cap. Flow
+$632M
Cap. Flow %
2.82%
Top 10 Hldgs %
24%
Holding
1,089
New
126
Increased
335
Reduced
435
Closed
161

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$146M
2
ADP icon
Automatic Data Processing
ADP
+$135M
3
MRK icon
Merck
MRK
+$120M
4
ODFL icon
Old Dominion Freight Line
ODFL
+$110M
5
NVDA icon
NVIDIA
NVDA
+$106M

Sector Composition

Rank Sector Weight
1 Technology 31.35%
2 Financials 14.63%
3 Consumer Discretionary 13.11%
4 Healthcare 11.31%
5 Industrials 9.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OGS icon
476
ONE Gas
OGS
$4.87B
$3.88M 0.02%
60,086
-151,484
-72% -$9.29M
NTRS icon
477
Northern Trust
NTRS
$33.3B
$3.84M 0.02%
+43,211
New +$3.54M
FDS icon
478
Factset
FDS
$9.36B
$3.81M 0.02%
8,383
-742
-8% -$346K
VMEO
479
DELISTED
Vimeo
VMEO
$3.8M 0.02%
928,413
+143,025
+18% +$610K
CRAI icon
480
CRA International
CRAI
$1.16B
$3.79M 0.02%
25,369
+19,943
+368% +$2.37M
CLW icon
481
Clearwater Paper
CLW
$339M
$3.78M 0.02%
86,532
-64,966
-43% -$2.4M
PTGX icon
482
Protagonist Therapeutics
PTGX
$8.79B
$3.73M 0.02%
129,011
INBK icon
483
First Internet Bancorp
INBK
$257M
$3.7M 0.02%
106,503
-21,271
-17% -$644K
JAZZ icon
484
Jazz Pharmaceuticals
JAZZ
$15.9B
$3.68M 0.02%
30,545
-9,116
-23% -$1.12M
CDXS icon
485
Codexis
CDXS
$151M
$3.65M 0.02%
1,046,676
-321,312
-23% -$1.01M
TXG icon
486
10x Genomics
TXG
$6B
$3.65M 0.02%
+97,172
New +$4.27M
MRSN
487
DELISTED
Mersana Therapeutics
MRSN
$3.63M 0.02%
32,395
-4,829
-13% -$480K
ARCH
488
DELISTED
Arch Resources, Inc.
ARCH
$3.6M 0.02%
22,416
-144
-0.6% -$24.6K
BOKF icon
489
BOK Financial
BOKF
$8.58B
$3.6M 0.02%
39,174
+7,412
+23% +$628K
HLIO icon
490
Helios Technologies
HLIO
$2.57B
$3.6M 0.02%
80,486
-427
-0.5% -$18.3K
ZUMZ icon
491
Zumiez
ZUMZ
$332M
$3.59M 0.02%
236,158
+34,638
+17% +$591K
SRDX
492
DELISTED
Surmodics
SRDX
$3.57M 0.02%
121,753
-6,212
-5% -$198K
FERG icon
493
Ferguson
FERG
$45.4B
$3.47M 0.02%
+15,880
New +$3.16M
DCH
494
Dauch Corp
DCH
$1.34B
$3.44M 0.02%
467,429
-393,356
-46% -$2.97M
RYAM icon
495
Rayonier Advanced Materials
RYAM
$604M
$3.43M 0.02%
717,391
+168,222
+31% +$716K
ARMK icon
496
Aramark
ARMK
$15B
$3.43M 0.02%
105,322
WYNN icon
497
Wynn Resorts
WYNN
$10.3B
$3.42M 0.02%
33,502
-4,884
-13% -$485K
ENTA icon
498
Enanta Pharmaceuticals
ENTA
$366M
$3.4M 0.02%
194,730
-366,291
-65% -$4.85M
RIGL icon
499
Rigel Pharmaceuticals
RIGL
$681M
$3.39M 0.02%
228,959
-39,463
-15% -$532K
CLDT
500
Chatham Lodging
CLDT
$622M
$3.37M 0.02%
333,406
-4,639
-1% -$48.4K

Similar funds

Jacobs Levy Equity Management's Q1 2024 Portfolio in Review

As of Q1 2024, Jacobs Levy Equity Management held 1,089 positions worth $22.4B, up 13% from $19.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Jacobs Levy Equity Management's Q1 2024 filing shows 126 new, 335 increased, 435 reduced and 161 closed positions. Its largest new stake was Crown Holdings: 378,261 shares worth $30M. The largest sale was AutoZone, an estimated $171M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Jacobs Levy Equity Management's largest Q1 2024 buy was Crown Holdings: 378,261 shares worth $30M.
  • Jacobs Levy Equity Management added most to Apple in Q1 2024, an estimated $146M increase.
  • Jacobs Levy Equity Management's biggest Q1 2024 reduction was AutoZone, cutting an estimated $171M.
  • Jacobs Levy Equity Management fully exited Fidelity National Information Services in Q1 2024, selling an estimated $94.5M.
  • Jacobs Levy Equity Management's ten largest holdings make up 24% of its $22.4B portfolio in Q1 2024.
  • Jacobs Levy Equity Management opened 126 new positions and closed 161 in Q1 2024.
  • Jacobs Levy Equity Management's portfolio value rose 13% quarter-over-quarter to $22.4B.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2024, filed 15 May 2024.